Last reviewed · How we verify
Dextromethophan
The clinical trial for Dextromethorphan, led by Duke University, has been discontinued, and as a result, its potential therapeutic indication and significance are no longer being explored. The discontinuation of this trial may be due to various reasons, including lack of efficacy or unforeseen side effects. Further research is needed to determine the full potential of this drug.
At a glance
| Generic name | Dextromethophan |
|---|---|
| Also known as | Delsym Cough Syrup |
| Sponsor | Duke University |
| Modality | Small molecule |
| Therapeutic area | Rare Disease |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |